NM_016507.4:c.3391A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016507.4(CDK12):​c.3391A>G​(p.Ile1131Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,614,184 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1131N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0088 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00087 ( 18 hom. )

Consequence

CDK12
NM_016507.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 1.07

Publications

3 publications found
Variant links:
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
CDK12 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022045374).
BP6
Variant 17-39525947-A-G is Benign according to our data. Variant chr17-39525947-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 133857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00882 (1344/152296) while in subpopulation AFR AF = 0.0306 (1273/41560). AF 95% confidence interval is 0.0292. There are 19 homozygotes in GnomAd4. There are 628 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK12NM_016507.4 linkc.3391A>G p.Ile1131Val missense_variant Exon 13 of 14 ENST00000447079.6 NP_057591.2 Q9NYV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK12ENST00000447079.6 linkc.3391A>G p.Ile1131Val missense_variant Exon 13 of 14 1 NM_016507.4 ENSP00000398880.4 Q9NYV4-1
CDK12ENST00000430627.6 linkc.3391A>G p.Ile1131Val missense_variant Exon 13 of 14 1 ENSP00000407720.2 Q9NYV4-2
CDK12ENST00000584632.5 linkc.3388A>G p.Ile1130Val missense_variant Exon 13 of 13 5 ENSP00000464641.1 J3QSD7
CDK12ENST00000559663.2 linkn.3391A>G non_coding_transcript_exon_variant Exon 13 of 21 5 ENSP00000453329.2 H0YLT2

Frequencies

GnomAD3 genomes
AF:
0.00883
AC:
1344
AN:
152178
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0307
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00241
AC:
605
AN:
251406
AF XY:
0.00167
show subpopulations
Gnomad AFR exome
AF:
0.0335
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000866
AC:
1266
AN:
1461888
Hom.:
18
Cov.:
32
AF XY:
0.000708
AC XY:
515
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0312
AC:
1043
AN:
33478
American (AMR)
AF:
0.00179
AC:
80
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000261
AC:
29
AN:
1112010
Other (OTH)
AF:
0.00179
AC:
108
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
70
141
211
282
352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00882
AC:
1344
AN:
152296
Hom.:
19
Cov.:
32
AF XY:
0.00843
AC XY:
628
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0306
AC:
1273
AN:
41560
American (AMR)
AF:
0.00373
AC:
57
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68030
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00655
Hom.:
7
Bravo
AF:
0.0107
ESP6500AA
AF:
0.0336
AC:
148
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00294
AC:
357
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CDK12-related disorder Benign:1
Feb 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
16
DANN
Benign
0.73
DEOGEN2
Benign
0.0083
T;.;T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.52
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.77
T;T;T
MetaRNN
Benign
0.0022
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.16
.;N;N
PhyloP100
1.1
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.010
.;N;N
REVEL
Benign
0.13
Sift
Benign
0.21
.;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
.;B;B
Vest4
0.10, 0.12
MVP
0.25
MPC
0.16
ClinPred
0.0043
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.015
gMVP
0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61747430; hg19: chr17-37682200; COSMIC: COSV104713587; API